Register
Login:
Share:
Email Facebook Twitter


James Bevan on cybersecurity, banks and the housing market


Verona Pharma Share Price (VRP)



Share Price Information for Verona Pharma (VRP)


Share Price: 147.50Bid: 145.00Ask: 150.00Change: 0.00 (0.00%)No Movement on Verona Pharma
Spread: 5.00Spread as %: 3.45%Open: 139.00High: 147.50Low: 139.00Yesterday’s Close: 147.50

Verona Pharma Plc Ord 5P

Verona Pharma is listed in the FTSE AIM All-Share
Verona Pharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
147.50

Share Price SpacerBid
145.00

Share Price SpacerAsk
150.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
117,400

Share Price SpacerOpen
139.00

Share Price SpacerHigh
147.50

Share Price SpacerLow
139.00

Share Price SpacerClose
147.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 104.55m £154.22m 1,000

52 Week High 151.50 52 Week High Date 9-MAR-2017
52 Week Low 2.80 52 Week Low Date 10-JUN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
31 66,955 50,445 -9.833 -15.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-May-17
17:07:41
147.50
500
 
145.00
150.00
737.50
Trade Type:
Ordinary

23-May-17
15:24:56
145.50
25,000
Sell* 
145.00
150.00
36.38k
Trade Type:
Ordinary

23-May-17
15:24:45
144.025
31,600
Sell* 
145.00
150.00
45.51k
Trade Type:
Ordinary




View more Verona Pharma trades >>

Directors Deals for Verona Pharma (VRP)
Trade DateActionNotifierPriceCurrencyAmountHolding
27-Apr-17Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
168.75GBX177,776283144
27-Apr-17Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
132GBX13,373117657
27-Apr-17Buy
Trade Notifier Information for Verona Pharma
Vikas Sinha held the position of Non-Executive Director at Verona Pharma at the time of this trade.
 Vikas Sinha
1.69USD177,7760
View more Verona Pharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Tue 20:58bewiseNasdaq147.50Strong Buy
Nice steady climb on Nasdaq....:)
Tue 19:09del1981RE: AIM/NASDAQ147.50No Opinion
Thanks for the clarification The Stranger.
Tue 15:17Industit was my poem146.50No Opinion
My poem was listened to
Tue 14:55rhodiJefferies conference NY146.50No Opinion
This is great platform as always but I believe that after this presentation we will see the share price continue on a pleasant trajectory and that AIM will follow suit riding on the coattails of the NASDAQ. More to follow for that I am fairly sure.
Tue 14:10funkym3Presentation146.50No Opinion
Company Verona Pharma plc
TIDM VRP
Headline Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference
Released 13:30 23-May-2017
Number HUG2107066

May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs, announced today that Jan-Anders Karlsson… Read More
Tue 12:52ThelixNice calm146.50No Opinion
incline over the next few weeks would be nice.

AIM is for traders NASDAQ for investors.

Should at least see a more stable price now hopefully.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Verona Pharma (VRP) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.